T1	AdverseReaction 60 70	infections
T2	AdverseReaction 239 265	Invasive fungal infections
T3	AdverseReaction 452 476	Hepatitis B reactivation
T4	AdverseReaction 628 640	Malignancies
T5	AdverseReaction 870 883;886 895	Heart failure Worsening
T6	AdverseReaction 870 883;900 909	Heart failure new onset
T7	AdverseReaction 991 1012	Demyelinating disease
T8	AdverseReaction 870 883	Heart failure
T9	AdverseReaction 1030 1039;991 1012	new onset Demyelinating disease
T10	AdverseReaction 1067 1093	Hypersensitivity reactions
T11	AdverseReaction 1103 1138	systemic hypersensitivity reactions
T12	Severity 1095 1102	Serious
T13	AdverseReaction 1149 1160	anaphylaxis
T14	AdverseReaction 1303 1313	infections
T15	Severity 1295 1302	serious
T16	Factor 1275 1279	risk
T17	AdverseReaction 1392 1397	death
T18	AdverseReaction 1403 1427	Opportunistic infections
T19	AdverseReaction 1403 1427;1435 1444	Opportunistic infections bacterial
T20	AdverseReaction 1403 1427;1446 1459	Opportunistic infections mycobacterial
T21	AdverseReaction 1403 1427;1461 1476	Opportunistic infections invasive fungal
T22	AdverseReaction 1403 1427;1478 1483	Opportunistic infections viral
T23	AdverseReaction 1403 1427;1488 1497	Opportunistic infections parasitic
T24	AdverseReaction 1518 1531	aspergillosis
T25	AdverseReaction 1533 1546	blastomycosis
T26	AdverseReaction 1548 1559	candidiasis
T27	AdverseReaction 1561 1579	coccidioidomycosis
T28	AdverseReaction 1581 1595	histoplasmosis
T29	AdverseReaction 1597 1610	legionellosis
T30	AdverseReaction 1612 1623	listeriosis
T31	AdverseReaction 1625 1639	pneumocystosis
T32	AdverseReaction 1645 1657	tuberculosis
T33	DrugClass 1682 1694	TNF-blockers
T34	Severity 52 59	Serious
T35	AdverseReaction 657 665	lymphoma
T36	AdverseReaction 784 796	malignancies
T37	Factor 911 914	may
T38	AdverseReaction 1014 1026;991 1012	exacerbation Demyelinating disease
T39	Factor 1041 1044	may
T40	Factor 1161 1164	may
T41	Factor 1361 1364	may
T42	AdverseReaction 3417 3445	reactivation of tuberculosis
T43	AdverseReaction 3449 3476	new tuberculosis infections
T44	AdverseReaction 6268 6301	reactivation of hepatitis B virus
T45	AdverseReaction 6268 6283;6303 6306	reactivation of HBV
T46	AdverseReaction 6486 6491	fatal
T47	AdverseReaction 6410 6426	HBV reactivation
T48	AdverseReaction 7882 7894	Malignancies
T49	AdverseReaction 7901 7906	fatal
T50	AdverseReaction 8134 8143	lymphomas
T51	AdverseReaction 8155 8164;8183 8191	Hodgkin's lymphoma
T52	AdverseReaction 8169 8191	non-Hodgkin's lymphoma
T53	AdverseReaction 8234 8246	malignancies
T54	AdverseReaction 8258 8275	rare malignancies
T55	AdverseReaction 8309 8326	immunosuppression
T56	AdverseReaction 9300 9308	lymphoma
T57	Factor 9598 9602	risk
T58	AdverseReaction 9675 9683	lymphoma
T59	AdverseReaction 9739 9744;9757 9765	acute leukemia
T60	AdverseReaction 9749 9765	chronic leukemia
T61	AdverseReaction 10089 10118	hepatosplenic T-cell lymphoma
T62	AdverseReaction 10120 10125	HSTCL
T63	AdverseReaction 10278 10283	fatal
T64	AdverseReaction 10197 10225	rare type of T-cell lymphoma
T65	AdverseReaction 10750 10758	Melanoma
T66	AdverseReaction 10876 10897	Merkel cell carcinoma
T68	AdverseReaction 11563 11575	malignancies
T69	AdverseReaction 11296 11308	malignancies
T67	AdverseReaction 11749 11761	malignancies
T70	AdverseReaction 12007 12041	worsening congestive heart failure
T71	AdverseReaction 12007 12016;12043 12046	worsening CHF
T72	AdverseReaction 12052 12065	new onset CHF
T73	AdverseReaction 12276 12293	CHF exacerbations
T74	AdverseReaction 12323 12342	increased mortality
T75	AdverseReaction 12831 12840;12860 12882;12889 12912	new onset central nervous system demyelinating disorders
T76	AdverseReaction 12924 12942	multiple sclerosis
T77	AdverseReaction 12944 12946	MS
T78	AdverseReaction 12952 12986	peripheral demyelinating disorders
T79	AdverseReaction 12998 13021	Guillain-Barre syndrome
T80	AdverseReaction 13032 13053	central demyelination
T81	AdverseReaction 13055 13057	MS
T82	AdverseReaction 13059 13073	optic neuritis
T83	AdverseReaction 13079 13118	peripheral demyelinating polyneuropathy
T84	AdverseReaction 14725 14737	pancytopenia
T85	AdverseReaction 14739 14749	leukopenia
T86	AdverseReaction 14751 14762	neutropenia
T87	AdverseReaction 14764 14779	aplastic anemia
T88	AdverseReaction 14785 14801	thrombocytopenia
T89	AdverseReaction 14868 14880	pancytopenia
T90	AdverseReaction 14882 14892	leukopenia
T91	AdverseReaction 14894 14905	neutropenia
T92	AdverseReaction 14911 14927	thrombocytopenia
T93	AdverseReaction 16035 16056	anaphylactic reaction
T94	AdverseReaction 15997 16023	hypersensitivity reactions
T95	Severity 15980 15987	serious
T96	AdverseReaction 12831 12840;12884 12887;12889 12912	new onset CNS demyelinating disorders
T97	AdverseReaction 12844 12882;12889 12912	exacerbation of central nervous system demyelinating disorders
T98	AdverseReaction 12844 12859;12884 12887;12889 12912	exacerbation of CNS demyelinating disorders
E1	AdverseReaction:T1 Effect:E35
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5 Hypothetical:E38
E6	AdverseReaction:T6 Hypothetical:E38
E8	AdverseReaction:T8 Hypothetical:E38
E9	AdverseReaction:T7 Hypothetical:E39
E10	AdverseReaction:T9 Hypothetical:E39
E11	AdverseReaction:T10
E12	AdverseReaction:T11 Effect:E13 Hypothetical:E40
E13	Severity:T12
E14	AdverseReaction:T13 Hypothetical:E40
E15	AdverseReaction:T14 Effect:E16 Hypothetical:E17
E16	Severity:T15
E17	Factor:T16
E18	AdverseReaction:T17 Hypothetical:E41
E19	AdverseReaction:T18
E20	AdverseReaction:T19 Hypothetical:E34
E21	AdverseReaction:T20 Hypothetical:E34
E22	AdverseReaction:T21 Hypothetical:E34
E23	AdverseReaction:T22 Hypothetical:E34
E24	AdverseReaction:T23 Hypothetical:E34
E25	AdverseReaction:T24 Hypothetical:E34
E26	AdverseReaction:T25 Hypothetical:E34
E27	AdverseReaction:T26 Hypothetical:E34
E28	AdverseReaction:T27 Hypothetical:E34
E29	AdverseReaction:T28 Hypothetical:E34
E30	AdverseReaction:T29 Hypothetical:E34
E31	AdverseReaction:T30 Hypothetical:E34
E32	AdverseReaction:T31 Hypothetical:E34
E33	AdverseReaction:T32 Hypothetical:E34
E34	DrugClass:T33
E35	Severity:T34
E36	AdverseReaction:T35
E37	AdverseReaction:T36
E38	Factor:T37
E7	AdverseReaction:T38 Hypothetical:E39
E39	Factor:T39
E40	Factor:T40
E41	Factor:T41
E42	AdverseReaction:T42
E43	AdverseReaction:T43
E44	AdverseReaction:T44
E45	AdverseReaction:T45
E46	AdverseReaction:T46
E47	AdverseReaction:T47
E48	AdverseReaction:T48
E49	AdverseReaction:T49
E50	AdverseReaction:T50
E51	AdverseReaction:T51
E52	AdverseReaction:T52
E53	AdverseReaction:T53
E54	AdverseReaction:T54
E55	AdverseReaction:T55
E56	AdverseReaction:T56
E57	Factor:T57
E58	AdverseReaction:T58 Hypothetical:E57
E59	AdverseReaction:T59
E60	AdverseReaction:T60
E61	AdverseReaction:T61
E62	AdverseReaction:T62
E63	AdverseReaction:T63
E64	AdverseReaction:T64
E65	AdverseReaction:T65
E66	AdverseReaction:T66
E68	AdverseReaction:T68
E69	AdverseReaction:T69
E67	AdverseReaction:T67
E70	AdverseReaction:T70
E71	AdverseReaction:T71
E72	AdverseReaction:T72
E73	AdverseReaction:T73
E74	AdverseReaction:T74
E75	AdverseReaction:T75
E76	AdverseReaction:T76
E77	AdverseReaction:T77
E78	AdverseReaction:T78
E79	AdverseReaction:T79
E80	AdverseReaction:T80
E81	AdverseReaction:T81
E82	AdverseReaction:T82
E83	AdverseReaction:T83
E84	AdverseReaction:T84
E85	AdverseReaction:T85
E86	AdverseReaction:T86
E87	AdverseReaction:T87
E88	AdverseReaction:T88
E89	AdverseReaction:T89
E90	AdverseReaction:T90
E91	AdverseReaction:T91
E92	AdverseReaction:T92
E93	AdverseReaction:T93
E94	AdverseReaction:T94 Effect:E95
E95	Severity:T95
E96	AdverseReaction:T96
E97	AdverseReaction:T97
E98	AdverseReaction:T98
A1	CUI E1 C3714514
A2	UMLS-Preferred-Name E1 Infection
A3	MEDDRA-PT E1 Infection
A4	MEDDRA-PT-ID E1 10021789
A5	CUI E2 C1262313
A6	UMLS-Preferred-Name E2 Invasive mycosis
A7	MEDDRA-PT E2 Systemic mycosis
A8	MEDDRA-PT-ID E2 10052366
A9	LLT E2 Invasive mycosis
A10	LLT-ID E2 10062642
A11	CUI E3 C1142420
A12	UMLS-Preferred-Name E3 Hepatitis B reactivation
A13	MEDDRA-PT E3 Hepatitis B
A14	MEDDRA-PT-ID E3 10019731
A15	LLT E3 Hepatitis B reactivation
A16	LLT-ID E3 10058827
A17	CUI E4 C0006826
A18	UMLS-Preferred-Name E4 Malignant Neoplasms
A19	MEDDRA-PT E4 Neoplasm malignant
A20	MEDDRA-PT-ID E4 10028997
A21	CUI E5 C0235875
A22	UMLS-Preferred-Name E5 Cardiac failure aggravated
A23	MEDDRA-PT E5 Cardiac failure
A24	MEDDRA-PT-ID E5 10007554
A25	LLT E5 Cardiac failure aggravated
A26	LLT-ID E5 10007557
A27	CUI E6 C0018801
A28	UMLS-Preferred-Name E6 Heart failure
A29	MEDDRA-PT E6 Cardiac failure
A30	MEDDRA-PT-ID E6 10007554
A31	CUI E9 C0011303
A32	UMLS-Preferred-Name E9 Demyelinating Diseases
A33	MEDDRA-PT E9 Demyelination
A34	MEDDRA-PT-ID E9 10012305
A35	LLT E9 Demyelination disorder NOS
A36	LLT-ID E9 10048425
A37	CUI E8 C0018801
A38	UMLS-Preferred-Name E8 Heart failure
A39	MEDDRA-PT E8 Cardiac failure
A40	MEDDRA-PT-ID E8 10007554
A41	LLT E8 Heart failure
A42	LLT-ID E8 10019279
A43	CUI E10 C0011303
A44	UMLS-Preferred-Name E10 Demyelinating Diseases
A45	MEDDRA-PT E10 Demyelination
A46	MEDDRA-PT-ID E10 10012305
A47	LLT E10 Demyelination disorder NOS
A48	LLT-ID E10 10048425
A49	CUI E11 C0020517
A50	UMLS-Preferred-Name E11 Hypersensitivity
A51	MEDDRA-PT E11 Hypersensitivity
A52	MEDDRA-PT-ID E11 10020751
A53	LLT E11 Hypersensitivity reaction
A54	LLT-ID E11 10020756
A55	CUI E12 C1736167
A56	UMLS-Preferred-Name E12 Systemic allergic reaction
A57	MEDDRA-PT E12 Hypersensitivity
A58	MEDDRA-PT-ID E12 10020751
A59	LLT E12 Systemic allergic reaction
A60	LLT-ID E12 10066472
A61	CUI E14 C0002792
A62	UMLS-Preferred-Name E14 anaphylaxis
A63	MEDDRA-PT E14 Anaphylactic reaction
A64	MEDDRA-PT-ID E14 10002198
A65	LLT E14 Anaphylaxis
A66	LLT-ID E14 10002218
A67	CUI E15 C3714514
A68	UMLS-Preferred-Name E15 Infection
A69	MEDDRA-PT E15 Infection
A70	MEDDRA-PT-ID E15 10021789
A71	CUI E18 C1306577
A72	UMLS-Preferred-Name E18 Death (finding)
A73	MEDDRA-PT E18 Death
A74	MEDDRA-PT-ID E18 10011906
A75	CUI E19 C0029118
A76	UMLS-Preferred-Name E19 Opportunistic Infections
A77	MEDDRA-PT E19 Opportunistic infection
A78	MEDDRA-PT-ID E19 10030901
A79	flag E20 duplicate
A80	CUI E20 C0029118
A81	UMLS-Preferred-Name E20 Opportunistic Infections
A82	MEDDRA-PT E20 Opportunistic infection
A83	MEDDRA-PT-ID E20 10030901
A84	flag E21 duplicate
A85	CUI E21 C0029118
A86	UMLS-Preferred-Name E21 Opportunistic Infections
A87	MEDDRA-PT E21 Opportunistic infection
A88	MEDDRA-PT-ID E21 10030901
A89	flag E22 duplicate
A90	CUI E22 C1262313
A91	UMLS-Preferred-Name E22 Invasive mycosis
A92	MEDDRA-PT E22 Systemic mycosis
A93	MEDDRA-PT-ID E22 10052366
A94	LLT E22 Invasive mycosis
A95	LLT-ID E22 10062642
A96	flag E23 duplicate
A97	CUI E23 C0042769
A98	UMLS-Preferred-Name E23 Virus Diseases
A99	MEDDRA-PT E23 Viral infection
A100	MEDDRA-PT-ID E23 10047461
A101	flag E24 duplicate
A102	CUI E24 C0747256
A103	UMLS-Preferred-Name E24 Parasitic infection
A104	MEDDRA-PT E24 Infection parasitic
A105	MEDDRA-PT-ID E24 10021857
A106	CUI E25 C0004030
A107	UMLS-Preferred-Name E25 Aspergillosis
A108	MEDDRA-PT E25 Aspergillus infection
A109	MEDDRA-PT-ID E25 10074171
A110	LLT E25 Aspergillosis
A111	LLT-ID E25 10003488
A112	CUI E26 C0005716
A113	UMLS-Preferred-Name E26 Blastomycosis
A114	MEDDRA-PT E26 Blastomycosis
A115	MEDDRA-PT-ID E26 10005098
A116	CUI E27 C0006840
A117	UMLS-Preferred-Name E27 Candidiasis
A118	MEDDRA-PT E27 Candida infection
A119	MEDDRA-PT-ID E27 10074170
A120	LLT E27 Candidiasis
A121	LLT-ID E27 10007152
A122	CUI E28 C0009186
A123	UMLS-Preferred-Name E28 Coccidioidomycosis
A124	MEDDRA-PT E28 Coccidioidomycosis
A125	MEDDRA-PT-ID E28 10009825
A126	CUI E29 C0019655
A127	UMLS-Preferred-Name E29 Histoplasmosis
A128	MEDDRA-PT E29 Histoplasmosis
A129	MEDDRA-PT-ID E29 10020141
A130	CUI E30 C0023240
A131	UMLS-Preferred-Name E30 Legionellosis
A132	MEDDRA-PT E30 Legionella infection
A133	MEDDRA-PT-ID E30 10061266
A134	CUI E31 C0023860
A135	UMLS-Preferred-Name E31 Listeriosis
A136	MEDDRA-PT E31 Listeriosis
A137	MEDDRA-PT-ID E31 10024641
A138	CUI E32 C1535939
A139	UMLS-Preferred-Name E32 Pneumocystis jiroveci pneumonia
A140	MEDDRA-PT E32 Pneumocystis jirovecii pneumonia
A141	MEDDRA-PT-ID E32 10073755
A142	LLT E32 Pneumocystosis
A143	LLT-ID E32 10035662
A144	CUI E33 C0041296
A145	UMLS-Preferred-Name E33 Tuberculosis
A146	MEDDRA-PT E33 Tuberculosis
A147	MEDDRA-PT-ID E33 10044755
A148	CUI E36 C0024299
A149	UMLS-Preferred-Name E36 Lymphoma
A150	MEDDRA-PT E36 Lymphoma
A151	MEDDRA-PT-ID E36 10025310
A152	CUI E37 C0006826
A153	UMLS-Preferred-Name E37 Malignant Neoplasms
A154	MEDDRA-PT E37 Neoplasm malignant
A155	MEDDRA-PT-ID E37 10028997
A156	CUI E7 C0011303
A157	UMLS-Preferred-Name E7 Demyelinating Diseases
A158	MEDDRA-PT E7 Demyelination
A159	MEDDRA-PT-ID E7 10012305
A160	LLT E7 Demyelination disorder NOS
A161	LLT-ID E7 10048425
A162	CUI E42 C0275965
A163	UMLS-Preferred-Name E42 Reactivation tuberculosis
A164	MEDDRA-PT E42 Tuberculosis
A165	MEDDRA-PT-ID E42 10044755
A166	LLT E42 Tuberculosis reactivated
A167	LLT-ID E42 10045025
A168	CUI E43 C0041296
A169	UMLS-Preferred-Name E43 Tuberculosis
A170	MEDDRA-PT E43 Tuberculosis
A171	MEDDRA-PT-ID E43 10044755
A172	LLT E43 Infection tuberculosis
A173	LLT-ID E43 10021870
A174	CUI E44 C1142420
A175	UMLS-Preferred-Name E44 Hepatitis B reactivation
A176	MEDDRA-PT E44 Hepatitis B
A177	MEDDRA-PT-ID E44 10019731
A178	LLT E44 Hepatitis B reactivation
A179	LLT-ID E44 10058827
A180	CUI E45 C1142420
A181	UMLS-Preferred-Name E45 Hepatitis B reactivation
A182	MEDDRA-PT E45 Hepatitis B
A183	MEDDRA-PT-ID E45 10019731
A184	LLT E45 Hepatitis B reactivation
A185	LLT-ID E45 10058827
A186	CUI E46 C1306577
A187	UMLS-Preferred-Name E46 Death (finding)
A188	MEDDRA-PT E46 Death
A189	MEDDRA-PT-ID E46 10011906
A190	CUI E47 C1142420
A191	UMLS-Preferred-Name E47 Hepatitis B reactivation
A192	MEDDRA-PT E47 Hepatitis B
A193	MEDDRA-PT-ID E47 10019731
A194	LLT E47 Hepatitis B reactivation
A195	LLT-ID E47 10058827
A196	CUI E48 C0006826
A197	UMLS-Preferred-Name E48 Malignant Neoplasms
A198	MEDDRA-PT E48 Neoplasm malignant
A199	MEDDRA-PT-ID E48 10028997
A200	CUI E49 C1306577
A201	UMLS-Preferred-Name E49 Death (finding)
A202	MEDDRA-PT E49 Death
A203	MEDDRA-PT-ID E49 10011906
A204	CUI E50 C0024299
A205	UMLS-Preferred-Name E50 Lymphoma
A206	MEDDRA-PT E50 Lymphoma
A207	MEDDRA-PT-ID E50 10025310
A208	CUI E51 C0019829
A209	UMLS-Preferred-Name E51 Hodgkin Disease
A210	MEDDRA-PT E51 Hodgkin's disease
A211	MEDDRA-PT-ID E51 10020206
A212	LLT E51 Hodgkin's lymphoma
A213	LLT-ID E51 10020328
A214	CUI E52 C0024305
A215	UMLS-Preferred-Name E52 Lymphoma, Non-Hodgkin
A216	MEDDRA-PT E52 Non-Hodgkin's lymphoma
A217	MEDDRA-PT-ID E52 10029547
A218	CUI E53 C0006826
A219	UMLS-Preferred-Name E53 Malignant Neoplasms
A220	MEDDRA-PT E53 Neoplasm malignant
A221	MEDDRA-PT-ID E53 10028997
A222	CUI E54 C0006826
A223	UMLS-Preferred-Name E54 Malignant Neoplasms
A224	MEDDRA-PT E54 Neoplasm malignant
A225	MEDDRA-PT-ID E54 10028997
A226	CUI E55 C1373218
A227	UMLS-Preferred-Name E55 Decreased Immunologic Activity [PE]
A228	MEDDRA-PT E55 Immunosuppression
A229	MEDDRA-PT-ID E55 10062016
A230	CUI E56 C0024299
A231	UMLS-Preferred-Name E56 Lymphoma
A232	MEDDRA-PT E56 Lymphoma
A233	MEDDRA-PT-ID E56 10025310
A234	CUI E58 C0024299
A235	UMLS-Preferred-Name E58 Lymphoma
A236	MEDDRA-PT E58 Lymphoma
A237	MEDDRA-PT-ID E58 10025310
A238	CUI E59 C0085669
A239	UMLS-Preferred-Name E59 Acute leukemia
A240	MEDDRA-PT E59 Acute leukaemia
A241	MEDDRA-PT-ID E59 10000830
A242	LLT E59 Acute leukemia
A243	LLT-ID E59 10000835
A244	CUI E60 C1279296
A245	UMLS-Preferred-Name E60 Chronic leukemia (category)
A246	MEDDRA-PT E60 Chronic leukaemia
A247	MEDDRA-PT-ID E60 10008943
A248	LLT E60 Chronic leukemia
A249	LLT-ID E60 10008948
A250	CUI E61 C1333984
A251	UMLS-Preferred-Name E61 Hepatosplenic T-cell lymphoma
A252	MEDDRA-PT E61 Hepatosplenic T-cell lymphoma
A253	MEDDRA-PT-ID E61 10066957
A254	CUI E62 C1333984
A255	UMLS-Preferred-Name E62 Hepatosplenic T-cell lymphoma
A256	MEDDRA-PT E62 Hepatosplenic T-cell lymphoma
A257	MEDDRA-PT-ID E62 10066957
A258	CUI E63 C1306577
A259	UMLS-Preferred-Name E63 Death (finding)
A260	MEDDRA-PT E63 Death
A261	MEDDRA-PT-ID E63 10011906
A262	CUI E64 C0079772
A263	UMLS-Preferred-Name E64 T-Cell Lymphoma
A264	MEDDRA-PT E64 T-cell lymphoma
A265	MEDDRA-PT-ID E64 10042971
A266	CUI E65 C0025202
A267	UMLS-Preferred-Name E65 melanoma
A268	MEDDRA-PT E65 Malignant melanoma
A269	MEDDRA-PT-ID E65 10025650
A270	LLT E65 Melanoma
A271	LLT-ID E65 10053571
A272	CUI E66 C0007129
A273	UMLS-Preferred-Name E66 Merkel cell carcinoma
A274	MEDDRA-PT E66 Neuroendocrine carcinoma of the skin
A275	MEDDRA-PT-ID E66 10029266
A276	LLT E66 Merkel cell carcinoma
A277	LLT-ID E66 10064025
A278	CUI E68 C0006826
A279	UMLS-Preferred-Name E68 Malignant Neoplasms
A280	MEDDRA-PT E68 Neoplasm malignant
A281	MEDDRA-PT-ID E68 10028997
A282	CUI E69 C0006826
A283	UMLS-Preferred-Name E69 Malignant Neoplasms
A284	MEDDRA-PT E69 Neoplasm malignant
A285	MEDDRA-PT-ID E69 10028997
A286	CUI E67 C0006826
A287	UMLS-Preferred-Name E67 Malignant Neoplasms
A288	MEDDRA-PT E67 Neoplasm malignant
A289	MEDDRA-PT-ID E67 10028997
A290	CUI E70 C3532952
A291	UMLS-Preferred-Name E70 Exacerbation of congestive heart failure
A292	MEDDRA-PT E70 Cardiac failure congestive
A293	MEDDRA-PT-ID E70 10007559
A294	LLT E70 Congestive cardiac failure aggravated
A295	LLT-ID E70 10048565
A296	CUI E71 C3532952
A297	UMLS-Preferred-Name E71 Exacerbation of congestive heart failure
A298	MEDDRA-PT E71 Cardiac failure congestive
A299	MEDDRA-PT-ID E71 10007559
A300	LLT E71 Congestive cardiac failure aggravated
A301	LLT-ID E71 10048565
A302	CUI E72 C0742752
A303	UMLS-Preferred-Name E72 CONGESTIVE HEART FAILURE NEW ONSET
A304	MEDDRA-PT E72 Cardiac failure congestive
A305	MEDDRA-PT-ID E72 10007559
A306	LLT E72 CHF
A307	LLT-ID E72 10008502
A308	CUI E73 C3532952
A309	UMLS-Preferred-Name E73 Exacerbation of congestive heart failure
A310	MEDDRA-PT E73 Cardiac failure congestive
A311	MEDDRA-PT-ID E73 10007559
A312	LLT E73 Congestive cardiac failure aggravated
A313	LLT-ID E73 10048565
A314	CUI E74 C1306577
A315	UMLS-Preferred-Name E74 Death (finding)
A316	MEDDRA-PT E74 Death
A317	MEDDRA-PT-ID E74 10011906
A318	CUI E75 C0011302
A319	UMLS-Preferred-Name E75 Demyelinating disease of central nervous system
A320	MEDDRA-PT E75 Demyelination
A321	MEDDRA-PT-ID E75 10012305
A322	LLT E75 Demyelinating disease of central nervous system, unspecified
A323	LLT-ID E75 10012301
A324	CUI E76 C0026769
A325	UMLS-Preferred-Name E76 Multiple Sclerosis
A326	MEDDRA-PT E76 Multiple sclerosis
A327	MEDDRA-PT-ID E76 10028245
A328	CUI E77 C0026769
A329	UMLS-Preferred-Name E77 Multiple Sclerosis
A330	MEDDRA-PT E77 Multiple sclerosis
A331	MEDDRA-PT-ID E77 10028245
A332	LLT E77 MS
A333	LLT-ID E77 10028053
A334	CUI E78 C0270922
A335	UMLS-Preferred-Name E78 Peripheral demyelinating neuropathy
A336	MEDDRA-PT E78 Demyelinating polyneuropathy
A337	MEDDRA-PT-ID E78 10061811
A338	CUI E79 C0018378
A339	UMLS-Preferred-Name E79 Guillain-Barre Syndrome
A340	MEDDRA-PT E79 Guillain-Barre syndrome
A341	MEDDRA-PT-ID E79 10018767
A342	CUI E80 C0338474
A343	UMLS-Preferred-Name E80 Central nervous system demyelination
A344	MEDDRA-PT E80 Demyelination
A345	MEDDRA-PT-ID E80 10012305
A346	LLT E80 Demyelinating disease of central nervous system, unspecified
A347	LLT-ID E80 10012301
A348	CUI E81 C0026769
A349	UMLS-Preferred-Name E81 Multiple Sclerosis
A350	MEDDRA-PT E81 Multiple sclerosis
A351	MEDDRA-PT-ID E81 10028245
A352	LLT E81 MS
A353	LLT-ID E81 10028053
A354	CUI E82 C0029134
A355	UMLS-Preferred-Name E82 Optic Neuritis
A356	MEDDRA-PT E82 Optic neuritis
A357	MEDDRA-PT-ID E82 10030942
A358	CUI E83 C4015271
A359	UMLS-Preferred-Name E83 Peripheral demyelinating polyneuropathy
A360	MEDDRA-PT E83 Demyelinating polyneuropathy
A361	MEDDRA-PT-ID E83 10061811
A362	CUI E84 C0030312
A363	UMLS-Preferred-Name E84 Pancytopenia
A364	MEDDRA-PT E84 Pancytopenia
A365	MEDDRA-PT-ID E84 10033661
A366	CUI E85 C0023530
A367	UMLS-Preferred-Name E85 Leukopenia
A368	MEDDRA-PT E85 Leukopenia
A369	MEDDRA-PT-ID E85 10024384
A370	CUI E86 C0027947
A371	UMLS-Preferred-Name E86 Neutropenia
A372	MEDDRA-PT E86 Neutropenia
A373	MEDDRA-PT-ID E86 10029354
A374	CUI E87 C0002874
A375	UMLS-Preferred-Name E87 Aplastic Anemia
A376	MEDDRA-PT E87 Aplastic anaemia
A377	MEDDRA-PT-ID E87 10002967
A378	LLT E87 Aplastic anemia
A379	LLT-ID E87 10002969
A380	CUI E88 C0040034
A381	UMLS-Preferred-Name E88 Thrombocytopenia
A382	MEDDRA-PT E88 Thrombocytopenia
A383	MEDDRA-PT-ID E88 10043554
A384	CUI E89 C0030312
A385	UMLS-Preferred-Name E89 Pancytopenia
A386	MEDDRA-PT E89 Pancytopenia
A387	MEDDRA-PT-ID E89 10033661
A388	CUI E90 C0023530
A389	UMLS-Preferred-Name E90 Leukopenia
A390	MEDDRA-PT E90 Leukopenia
A391	MEDDRA-PT-ID E90 10024384
A392	CUI E91 C0027947
A393	UMLS-Preferred-Name E91 Neutropenia
A394	MEDDRA-PT E91 Neutropenia
A395	MEDDRA-PT-ID E91 10029354
A396	CUI E92 C0040034
A397	UMLS-Preferred-Name E92 Thrombocytopenia
A398	MEDDRA-PT E92 Thrombocytopenia
A399	MEDDRA-PT-ID E92 10043554
A400	CUI E93 C0002792
A401	UMLS-Preferred-Name E93 anaphylaxis
A402	MEDDRA-PT E93 Anaphylactic reaction
A403	MEDDRA-PT-ID E93 10002198
A404	CUI E94 C0020517
A405	UMLS-Preferred-Name E94 Hypersensitivity
A406	MEDDRA-PT E94 Hypersensitivity
A407	MEDDRA-PT-ID E94 10020751
A408	LLT E94 Hypersensitivity reaction
A409	LLT-ID E94 10020756
A410	CUI E96 C0011302
A411	UMLS-Preferred-Name E96 Demyelinating disease of central nervous system
A412	MEDDRA-PT E96 Demyelination
A413	MEDDRA-PT-ID E96 10012305
A414	LLT E96 Demyelinating disease of central nervous system, unspecified
A415	LLT-ID E96 10012301
A416	CUI E97 C0011302
A417	UMLS-Preferred-Name E97 Demyelinating disease of central nervous system
A418	MEDDRA-PT E97 Demyelination
A419	MEDDRA-PT-ID E97 10012305
A420	LLT E97 Demyelinating disease of central nervous system, unspecified
A421	LLT-ID E97 10012301
A422	CUI E98 C0011302
A423	UMLS-Preferred-Name E98 Demyelinating disease of central nervous system
A424	MEDDRA-PT E98 Demyelination
A425	MEDDRA-PT-ID E98 10012305
A426	LLT E98 Demyelinating disease of central nervous system, unspecified
A427	LLT-ID E98 10012301
